The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rhinolast 140 micrograms per Spray, Nasal Spray

0.1 percent weight/volume Nasal spray, solution

Mylan IRE Healthcare LimitedPA2010/037/001

Main Information

Trade NameRhinolast 140 micrograms per Spray, Nasal Spray
Active SubstancesAzelastine hydrochloride
Strength0.1 percent weight/volume
Dosage FormNasal spray, solution
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/037/001

Group Information

ATC CodeR01AC Antiallergic agents, excl. corticosteroids
R01AC03 azelastine


Licence Issued15/12/1994
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back